  The purpose of this study was to quantitatively evaluate the visibility and
artifacts of commercially available fiducial markers in order to optimize their
selection for image-guided stereotactic body radiation therapy (SBRT). From six
different vendors, we selected 11 fiducials commonly used in image-guided
radiation therapy (IGRT); the fiducials varied in material composition (gold,
platinum, carbon), shape (cylindrical, notched/linear, coiled, ball-like,
step), and size measured in terms of diameter (0.28-1.0 mm) and length
(3.0-20.0 mm). Each fiducial was centered in 4-mm bolus within a 13-cm-thick
water-equivalent phantom. Fiducials were imaged with use of a simulation
computed tomography (CT) scanner, a CT-on-rails system, and an onboard
cone-beam CT system. Acquisition parameters were set according to clinical
protocols. Visibility was assessed in terms of contrast and the Michelson
visibility metric. Artifacts were quantified in terms of relative standard
deviation and relative streak artifacts level (rSAL). Twelve radiation
oncologists ranked each fiducial in terms of clinical usefulness. Contrast and
artifacts increased with fiducial size. For CT imaging, maximum contrast (2722
HU) and artifacts (rSAL=2.69) occurred for the largest-diameter (0.75 mm)
platinum fiducial. Minimum contrast (551 HU) and reduced artifacts (rSAL=0.65)
were observed for the smallest-diameter (0.28 mm) gold fiducial. Carbon
produced the least severe artifacts (rSAL = 0.29). The survey indicated that
physicians preferred gold fiducials with a 0.35- to 0.43-mm diameter, 5- to
10-mm length, and a coiled or cylindrical shape that balanced contrast and
artifacts. We evaluated 11 different fiducials in terms of visibility and
artifacts. The results of this study may assist radiation oncologists who seek
to maximize contrast, minimize artifacts, and/or balance contrast versus
artifacts by fiducial selection.
